Profil
Gregory Stea served as Vice President-Sales at Amgen, Inc. from 1988 to 1997.
He then worked as Principal at Glaxo Pharmaceuticals, Inc. from 1982 to 1988.
Later, he served as Senior Vice President-Commercial Operations at Cubist Pharmaceuticals LLC from 2002 to 2015.
From 2015 to 2019, he worked as Independent Director at Achaogen, Inc. Mr. Stea completed his undergraduate degree from Temple University (Pennsylvania).
Anciens postes connus de Gregory Stea
| Sociétés | Poste | Fin |
|---|---|---|
| ACHAOGEN | Directeur/Membre du Conseil | 23/07/2019 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/02/2015 |
| AMGEN INC. | Sales & Marketing | 01/01/1997 |
| Glaxo Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Formation de Gregory Stea
| Temple University (Pennsylvania) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
| Glaxo Pharmaceuticals, Inc. | |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
